Black Money Worldwide

The African, African-American and Caribbean business daily

Pfizer Chief Medical Officer

Dr. Aida Habtezion

Ballinger-Swindells Family Scholar, Associate Dean for Academic Affairs in the School of Medicine and member of the Stanford Pancreas Cancer Research Group, Stanford Diabetes Research Center, Stanford Neuroscience Institute, Stanford Bio-X, Stanford maternal & Child Health Research Institute and a fellow of the Stanford Chemistry, Engineering & Medicine for Human Health (ChEM-H)



The Journal of Black Innovation has selected Dr. Aida Habtezion among the second annual BlackBio100.

As Chief Medical Officer of Pfizer, Aida Habtezion leads Pfizer's Worldwide Medical & Safety organization responsible for ensuring that patients, physicians, and regulatory agencies are provided with information on the safe and appropriate use of Pfizer medications.

Prior to joining Pfizer, Dr. Habtezion was a practicing physician and scientist at Stanford University's School of Medicine, Gastroenterology, and Digestive Health Clinic. She led an NIH-funded translational lab focused on understanding immune mechanisms and identifying potential immune-based therapeutic targets for pancreatitis and inflammatory bowel disease. While working in the lab, she served as a tenured Associate Professor of Medicine specializing in gastroenterology and hepatology, an Associate Dean for Academic Affairs, a faculty member in Stanford's Immunology Ph.D. program, Neuroscience Institute, Cancer Institute, Maternal & Child Health Research Institute, and faculty fellow at Stanford's ChEM-H (Chemistry, Engineering & Medicine for Human Health) at Stanford University School of Medicine. Dr. Habtezion is a tenured professor and currently on a leave of absence from Stanford.

Dr. Habtezion is the recipient of the Robert Wood Johnson Harold Amos Medical Faculty Development Award, Gastroenterology & Hepatology Teaching Award, the Immunology Faculty Mentor of the Year, Synergy Award from the Kenneth Rainin Foundation for her research in Inflammatory Bowel Disease and was named the Allen Distinguished Investigator. She was elected into the American Society for Clinical Investigation, Association of American Physicians, and the American Pancreas Association (APA) Council. Currently, she is the APA President-elect.

Dr. Habtezion obtained her Bachelor of Science in Chemistry from the University of Alberta and Master of Science in Nutritional Sciences at the University of Guelph. She completed her medical degree from McMaster University. Dr. Habtezion completed her Internal Medicine residency from the University of Western Ontario and Gastroenterology & Hepatology clinical fellowship from the University of Toronto in Canada. Following her clinical fellowship training, she obtained postdoctoral research training in Immunology at Stanford University.

Dr. Habtezion was born in Eritrea and has lived on three continents and four countries. She enjoys traveling, music, and learning about different cultures.